Habitus Associates Co., LTD
SEOUL, SOUTH KOREA / ACCESSWIRE / September 17, 2023 / Habitus Associates Co., LTD., the entity behind the online art platform 'Artue' and under the leadership of Bo Young SONG, has secured a seed investment of 4 billion won. This investment round was led by SoftBank Ventures Asia with several angel investors also taking part.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Artue, powered by Habitus Associates Co., LTD, is pioneering the art industry's digital transformation. The platform is revolutionizing the traditionally offline, high-barrier art brokerage, providing emerging artists with market entry opportunities and reducing purchasing barriers for collectors.
A notable feature of Artue is its digital twin technology, enabling a virtual experience that mirrors physical art spaces. With the integration of online transactional capabilities, Artue is also enhancing its digital Catalogue Raisonné service and introducing resale functionalities.
The team at Habitus Associates Co., LTD. comprises industry veterans from influential corporations like Naver, Kakao, Credit-Suisse, LG, Hyundai Motor Group, Kukje Gallery, and Korea Arts Management Service. The advisory board includes Eugene Whang, with two decades at Apple; Alan Lau, previously of Tencent and now with Animoca Brands; Changwook Kim of Naver; and Federico Tan, a communications specialist with clients including Sacai and Takashi Murakami.
With the new funds, the company intends to further develop and hone Artue's offerings, boost its technical capabilities, and expand its reach. Strategic talent acquisition and international artist promotion are also on the agenda, along with securing additional intellectual properties to diversify Artue's portfolio.
In 2022, the global art market was valued at an impressive 80 trillion won, with projections indicating continued growth driven by an increase in affluent individuals and the expanding digital landscape. Remarkably, South Korea's art market achieved over 1 trillion won in sales during the challenging pandemic year. Estimates for 2022 show potential growth to 1.377 trillion won. With Seoul witnessing a surge in global galleries and auction houses, South Korea is positioning itself as a significant player in the art market alongside giants like the US, UK, China, and Japan.
Bo Young SONG, co-founder of Habitus Associates Co., LTD., has served as a member of the Selection Committee member of Art Basel Hong Kong for a decade and as the first Asian partner and the regional CEO of renowned European art publisher Cahiers d'Art. She stated, "Artue is our response to the digital era. Beyond traditional art experiences, our platform aims to expedite and enhance the journey of gallerists, artists, and collectors."
JP Lee, CEO of SoftBank Ventures Asia, added, "Habitus Associates Co., LTD. seamlessly integrates art with IT, revolutionizing the traditional art market. We will actively support the continued growth of Artue and, furthermore, the digital transition of the art market."
Contact Information
Ines On Sim
Communications Manager
ines@artue.io
+82-10-6298-5999
Related Files
About SoftBank Ventures Asia & Habitus Associates.docx
SOURCE: Habitus Associates Co., LTD
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/784622/softbank-ventures-asia-invests-in-habitus-associates-co-ltd-leading-the-digital-transition-of-the-art-industry
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release
MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o
GA-ASI and Saab Will Demonstrate AEW&C on MQ-9B in 202617.11.2025 03:05:00 CET | Press release
Two Aerospace Leaders Are Bringing Airborne Early Warning and Control to UAS DUBAI, UAE / ACCESS Newswire / November 16, 2025 / Following their announcement to bring Airborne Early Warning and Control (AEW&C) capability to the world's leading Remotely Piloted Aircraft (RPA) platform, General Atomics Aeronautical Systems, Inc. (GA-ASI) and Saab will now team up to demonstrate the capability in the summer of 2026. The demo will be conducted at GA-ASI's Desert Horizon flight operations facility in Southern California using a GA-ASI MQ-9B equipped with AEW&C supplied by Saab. In partnership with Saab, a leading company in AEW&C systems, GA-ASI is pairing Saab's AEW sensors with the world's longest-range, highest-endurance RPA, the MQ-9B. At sea or over land, adding AEW capabilities on MQ-9B enables persistent air surveillance and enables AEW in areas of the world where it doesn't currently exist or is unaffordable, such as for navy aircraft carriers at sea. "Adding AEW&C to the MQ-9B bring
Doha Tattoo Festival Announced as Ticket Sales Officially Open16.11.2025 12:45:00 CET | Press release
DOHA, QA / ACCESS Newswire / November 16, 2025 / Under the patronage of His Excellency Sheikh Khalifa bin Hamad bin Khalifa Al Thani, Minister of Interior and Commander of the Internal Security Force (Lekhwiya), the first edition of the Doha International Music and Marching Festival (Doha Tattoo) will be held from 16 to 20 December 2025 at Katara Cultural Village. A press conference held at Katara Cultural Village unveiled the line-up of participating bands and ticket details, attended by members of the Doha Tattoo organising committee and partner representatives. The Doha Tattoo will combine precision with musical artistry, showcasing performances by distinguished musical bands from seven countries: the United Kingdom, the United States of America, Turkia, Hashemite Kingdom of Jordan , the Sultanate of Oman, Kazakhstan, and the State of Qatar. The participating line-up includes the Irish Guards and the Royal Air Force Music Services from the United Kingdom, the United States Air Force
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom